Bioceres Crop Solutions (BIOX) 2024年年度报告「NASDAQ」.pdf

1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 20-F(Mark One)REGISTRATION STATEMENT PURSUANT TO SECTION 12(b)OR(g)OF THE SECURITIES EXCHANGE ACT OF 1934ORANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year e

2、nded June 30,2024ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to ORSHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934Date of event requiring this shell company report:Commission file nu

3、mber:001-38405Bioceres Crop Solutions Corp.(Exact name of Registrant as specified in its charter)Cayman Islands(Jurisdiction of incorporation)Ocampo 210 bis,Predio CCT,RosarioProvince of Santa Fe,Argentina(Address of principal executive offices)Maria Paula SavantiHead of Investor RelationsOcampo 210

4、 bis,Predio CCT,RosarioProvince of Santa Fe,ArgentinaPhone:54-341-4861122Email:(Name,Telephone,E-mail and/or Facsimile number and Address of Company Contact Person)Copies to:Matthew S.Poulter,Esq.Emilio Minvielle,Esq.Linklaters LLP1290 Avenue of the AmericasNew York,NY 10104Phone:(212)903-9000Fax:(2

5、12)903-9100Securities registered or to be registered pursuant to Section 12(b)of the Act:Title of Each Class Trading Symbol Name of each exchange on which registeredOrdinary Shares,par value US$0.0001 per share BIOX Nasdaq Stock Market LLCTable of ContentsSecurities registered or to be registered pu

6、rsuant to Section 12(g)of the Act:NoneSecurities for which there is a reporting obligation pursuant to Section 15(d)of the Act:Ordinary SharesIndicate the number of outstanding shares of each of the issuers classes of capital stock or common stock as of the close of business covered by the annualrep